Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: Long-term results of MSFOP 98

Journal of Clinical Oncology

Volumn 27, Issue 11, 2009, Pages 1879-1883

  Carrie, Christian ^a,b   Grill, Jacques ^c   Figarella Branger, Dominique ^c   Bernier, Valerie ^c   Padovani, Laetitia ^c   Habrand, Jean Louis ^c   Benhassel, Mohamed ^c   Mege, Martine ^c   Mahé, Marc ^c   Quetin, Philippe ^c   Maire, Jean Philippe ^c   Baron, Marie Helene ^c   Clavere, Pierre ^c   Chapet, Sophie ^c   Maingon, Philippe ^c   Alapetite, Claire ^c   Claude, Line ^c   Laprie, Anne ^c   Dussart, Sophie ^c  

^a UNIVERSITÉ DE LYON   (France)

^b CENTRE LÉON BÉRARD   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; ATTRIBUTABLE RISK; CANCER RECURRENCE; CANCER RELAPSE; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTELLIGENCE QUOTIENT; MALE; MEDULLOBLASTOMA; NEUROPSYCHOLOGICAL TEST; NEUTROPENIA; ONLINE SYSTEM; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY CONTROL; SCHOOL CHILD; SKIN TOXICITY; THROMBOCYTOPENIA; WECHSLER INTELLIGENCE SCALE; WISCONSIN CARD SORTING TEST;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FOLLOW-UP STUDIES; HUMANS; INTERNET; LONGITUDINAL STUDIES; MEDULLOBLASTOMA; QUALITY CONTROL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS;

EID: 64649086763     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.18.6437     Document Type: Article

References (30)

1. Freeman CR, Taylor RE, Kortmann RD, et al: Radiotherapy for medulloblastoma in children: A perspective on current international clinical research efforts. Med Pediatr Oncol 39:99-108, 2002
2. Thomas PR, Deutsch M, Kepner JL, et al: Low-stage medulloblastoma: Final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 18:3004-3011, 2000
3. Kieffer-Renaux V, Bulteau C, Grill J, et al: Patterns of neuropsychological deficits in children with medulloblastoma according to craniospatial irradiation doses. Dev Med Child Neurol 42:741-745, 2000
4. Oyharcabal-Bourden V, Kalifa C, Gentet JC, et al: Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: A French Society of Pediatric Oncology Study. J Clin Oncol 23:4726-4734, 2005
5. Packer RJ, Gajjar A, Vezina G, et al: Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24:4202-4208, 2006
6. Carrie C, Alapetite C, Mere P, et al: Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: The contribution of radiotherapy technique to tumour relapse: The French Medulloblastoma Group. Radiother Oncol 24:77-81, 1992
7. Carrie C, Hoffstetter S, Gomez F, et al: Impact of targeting deviations on outcome in medulloblastoma: Study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 45:435-439, 1999
8. Allen JC, Donahue B, DaRosso R, et al: Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. Int J Radiat Oncol Biol Phys 36:1155-1161, 1996
9. Prados MD, Wara WM, Edwards MS, et al: Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: Early results of a pilot study. Int J Radiat Oncol Biol Phys 28:431-438, 1994
10. Merchant TE, Kun LE, Krasin MJ, et al: Multi-institution prospective trial of reduced-dose cranio-spinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Int J Radiat Oncol Biol Phys 70:782-787, 2008
11. Wolden SL, Dunkel IJ, Souweidane MM, et al: Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma. J Clin Oncol 21:3079-3083, 2003
12. Halperin EC: Impact of radiation technique upon the outcome of treatment for medulloblastoma. Int J Radiat Oncol Biol Phys 36:233-239, 1996
13. Fukunaga-Johnson N, Lee JH, Sandler HM, et al: Patterns of failure following treatment for medulloblastoma: Is it necessary to treat the entire posterior fossa? Int J Radiat Oncol Biol Phys 42:143-146, 1998
14. Carrie C, Muracciole X, Gomez F, et al: Con- formal radiotherapy, reduced boost volume, hyper-fractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: Results of the French M-SFOP 98 protocol. Int J Radiat Oncol Biol Phys 63:711-716, 2005
15. Ellison DW, Onilude OE, Lindsey JC, et al: Beta-catenin status predicts a favorable outcome in childhood medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol 23:7951-7957, 2005
16. Gajjar A, Chintagumpala M, Ashley D, et al: Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol 7:813-820, 2006
17. Bellissant E, Benichou J, Chastang C: The group sequential triangular test for phase II cancer clinical trials. Am J Clin Oncol 19:422-430, 1996
18. Kortmann RD, Kuhl J, Timmermann B, et al: Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 46:269-279, 2000
19. Palmer SL, Goloubeva O, Reddick WE, et al: Patterns of intellectual development among survivors of pediatric medulloblastoma: A longitudinal analysis. J Clin Oncol 19:2302-2308, 2001
20. Ris MD, Packer R, Goldwein J, et al: Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: A Children's Cancer Group study. J Clin Oncol 19:3470-3476, 2001
21. Fouladi M, Chintagumpala M, Laningham FH, et al: White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol 22:4551-4560, 2004
22. Mulhern RK, Palmer SL, Merchant TE, et al: Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23:5511-5519, 2005
23. Spiegler BJ, Bouffet E, Greenberg ML, et al: Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 22:706-713, 2004
24. Walter AW, Mulhern RK, Gajjar A, et al: Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol 17:3720-3728, 1999
25. Grill J, Escolano S, Kieffer V, et al: Evaluation of IQ in children with medulloblastoma: Comparison of estimated IQ from three subtests with full scale IQ. Proceedings of the International Symposium of Pediatric Neuro-Oncology, Nara, Japan, June 2-6, 2006; Neuro-Oncol 8:9, 2007 (suppl 1; abstr 36)
26. Kieffer-Renaux V, Viguier D, Raquin MA, et al: Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors. Pediatr Blood Cancer 45:814-819, 2005
27. Bull KS, Spoudeas HA, Yadegarfar G, et al: Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: A follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG). J Clin Oncol 25:4239-4245, 2007
28. Grill J, Renaux VK, Bulteau C, et al: Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 45:137-145, 1999
29. Merchant TE, Happersett L, Finlay JL, et al: Preliminary results of conformal radiation therapy for medulloblastoma. Neuro Oncol 1:177-187, 1999
30. Ricardi U, Corrias A, Einaudi S, et al: Thyroid dysfunction as a late effect in childhood medullo- blastoma: A comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 50:1287-1294, 2001